相关实验视频

Updated: Jun 27, 2025

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker

Published on: March 31, 2018

FABP4对老年人群中心血管疾病的影响

Ellen M van der Ark-Vonk¹, Mike V Puijk¹, Gerard Pasterkamp¹

¹Central Diagnostics Laboratory, Division Laboratory, Pharmacy, and Biomedical Genetics, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.

Current atherosclerosis reports

|May 2, 2024

概括

脂肪酸结合蛋白4 (FABP4) 与心血管疾病和动脉样硬化有关. 研究探讨了FABP4的研究.

科学领域:

生物化学和分子生物学
心血管疾病研究研究
药理学药理学是指药理学的学科.

背景情况:

脂肪酸结合蛋白4 (FABP4) 是脂质代谢和心血管健康的组成部分.
FABP4影响包括JAK2/STAT2和c-kit在内的细胞通路,影响炎症和血管生成.
血清FABP4水平升高被认为是心血管疾病风险的预测生物标志物.

研究的目的:

审查FABP4的生物学及其在心血管疾病中的作用.
检查对FABP4血清水平及其与动脉样硬化相关性的遗传影响.
讨论目前针对FABP4的药物开发以及未来的研究方向.

主要方法:

对将FABP4与动脉样硬化联系起来的观察性研究的综述.
对FABP4血清水平 (例如,PPARG变体) 的遗传研究的分析.
对FABP4抑制剂正在进行的药物发现计划的评估.

主要成果:

FABP4促进血管新生和血管光滑肌肉细胞的增殖,加速动脉样硬化疾病.
PPARG中的遗传变异与FABP4血清水平密切相关.
在风险人群中,FABP4是心血管疾病的可靠预测生物标志物.

结论:

FABP4水平升高与心血管风险增加和动脉样硬化有因果关系.
药物发现工作正在进行中,以开发FABP4抑制剂,尽管临床试验有限.
进一步研究FABP4基因及其在心血管疾病中的因果作用,特别是老年人群中,是有必要的.

关键词:

动脉样硬化是一种动脉样硬化.心血管疾病是什么心血管疾病在 FABP4 中,FABP4 是最常见的.斑块斑块斑块斑块斑块斑块我们的eQTL是eQTL.

更多相关视频

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

相关概念视频

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...